CEPI CEO says Korea can play key role in '100 days mission' for vaccine development
Korea can play a key role in the "100 days mission" for vaccine development for emerging infectious diseases, the chief executive of the Coalition for Epidemic Preparedness Innovations (CEPI) has said, calling Seoul a "global leader" in pandemic response. CEPI CEO Richard Hatchett made the remarks in an interview with Yonhap News Agency in Seoul on Friday, noting his agency has been discussing expanding partnership with Korea to support global efforts to develop emergency vaccines for infectious diseases within 100 days of an outbreak. Hatchett was on a two-day trip to Seoul to discuss the matter with the Korean government, the private sector and academic institutions. "Why Korea? The strong central government, clinical trial capability, strong institutions and private sector partners," Hatchett said of reasons for the ongoing efforts to hold such an exercise in Korea. "Korea was a global leader from its excellent response to the early days of the COVID-19 pandemic and a global leader in its efforts to pursue the 100 days mission." CEPI's 100 days mission was launched in 2022 to bolster t
Mar 19, 2025By yonhap
